ABCL

#2044
AbCellera Biologics Inc. Common Shares
3.61
+3.74%
Sector:
Base:
Profit Currency:
Daily Range
3.61
3.61
Year Range
1.89
6.52
Daily Change
+3.74%
Monthly Change
-10.86%
6 month change
-18.51%
Year Change
+32.72%
Previous Close
3.48
Open
3.61
Bid
Ask
Low
3.61
High
3.61
Volume
47
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20212022202320242025 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

News